bipolar depression

Titusville, New Jersey, U.S., September 21, 2026 Johnson & Johnson has announced positive topline results from a pivotal Phase...

Abbott Park, Illinois, U.S., September 8, 2026 Abbott has received U.S. FDA approval for its TactiFlex™ Duo Ablation Catheter,...

Titusville, New Jersey, U.S., September 8, 2026 Johnson & Johnson is set to present new clinical and real-world evidence...

MIAMI, August 7, 2026 NRx Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has completed the first-cycle...

New York, July 22, 2026 LB Pharmaceuticals announced that it now expects to report topline results from the pivotal...

NEW YORK, November 6, 2025 — LB Pharmaceuticals Inc. (NASDAQ: LBRX), a clinical-stage biopharmaceutical company focused on developing therapies...